Search alternatives:
5 we » _ we (Expand Search)
Showing 1 - 20 results of 100 for search '(( 5 _ decrease ) OR ((( 19 _ decrease ) OR ( 5 we decrease ))))~', query time: 0.14s Refine Results
  1. 1
  2. 2

    Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections by Qassim, Suelen H.

    Published 2022
    “…Using the cycle threshold (Ct) value of an RT-qPCR-positive test to proxy the inverse of infectiousness, we investigated infectiousness of SARS-CoV-2 infections by variant, age, sex, vaccination status, prior infection status, and reason for testing in a random sample of 18,355 RT-qPCR-genotyped infections. …”
    Get full text
    Get full text
    Get full text
  3. 3

    SARS-CoV-2: An Analysis of the Vaccine Candidates Tested in Combatting and Eliminating the COVID-19 Virus by Elmancy, Laila

    Published 2022
    “…Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), better known as COVID-19, is a highly contagious virus, transferable via air droplets from close human-human contact. …”
    Get full text
    Get full text
    Get full text
  4. 4

    Host genetic variants potentially associated with SARS-CoV-2: A multi-population analysis by Smatti, Maria K.

    Published 2020
    “…Methods: We extracted the list of SNPs that could potentially modulate SARS-CoV-2 from the genome wide association studies (GWAS) on SARS-CoV-1 and other viruses. …”
    Get full text
    Get full text
  5. 5

    Host Genetic Variants Potentially Associated With SARS-CoV-2: A Multi-Population Analysis. by Smatti, Maria K

    Published 2020
    “…We extracted the list of SNPs that could potentially modulate SARS-CoV-2 from the genome wide association studies (GWAS) on SARS-CoV-1 and other viruses. …”
    Get full text
    Get full text
  6. 6

    Reinfections in COVID-19 Patients: Impact of Virus Genetic Variability and Host Immunity by Fakhroo, Aisha

    Published 2021
    “…The rapid spread of these new variants has raised concerns about the multiple waves of infections and the effectiveness of available vaccines. In this review, we discuss SARS-CoV-2 reinfection rates in previously infected and vaccinated individuals in relation to humoral responses. …”
    Get full text
    Get full text
  7. 7
  8. 8
  9. 9

    An evidence base for school health policy during the covid-19 pandemic by Badran, S.

    Published 2021
    “…Methods: We gathered age-specific COVID-19 case counts and identified mortality data for 14 countries. …”
    Get full text
    Get full text
  10. 10

    SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines by Zedan, Hadeel T.

    Published 2024
    “…However, their antibody-dependent cellular cytotoxicity (ADCC) functionality is still poorly characterized. Here, we investigated ADCC activity in convalescent sera from infected patients with wild-type (WT) severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) or omicron variant compared with three coronavirus disease 2019 (COVID-19) vaccine platforms and postvaccination breakthrough infection (BTI). …”
    Get full text
    Get full text
    Get full text
  11. 11
  12. 12

    Follow up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals ov... by Salma, Younes

    Published 2023
    “…We measured the levels of neutralizing total antibodies (NtAbs), anti-S-RBD IgG, and anti-S1 IgA titers among VN and NI up to ∼10 months from administration of the first dose, and up to ∼7 months from SARS-CoV-2 infection, respectively. …”
    Get full text
    Get full text
    Get full text
  13. 13

    Follow up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals ov... by Salma, Younes

    Published 2023
    “…We measured the levels of neutralizing total antibodies (NtAbs), anti-S-RBD IgG, and anti-S1 IgA titers among VN and NI up to ∼10 months from administration of the first dose, and up to ∼7 months from SARS-CoV-2 infection, respectively. …”
    Get full text
    Get full text
    Get full text
    article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20